Photoinactivation of Leishmania donovani infantum in red cell suspensions by a flexible thiopyrylium sensitizer

Vox Sanguinis

Volumn 91, Issue 2, 2006, Pages 178-180

  Wagner, S J ^a,c   Skripchenko, A ^a   Salata, J ^b   Cardo, L J ^b  

^a HOLLAND LABORATORY   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c AMERICAN RED CROSS   (United States)

Author keywords

Inactivation; Leishmania; Pathogen reduction; Photosensitizer; Red cell

Indexed keywords

DNA; PHOTOSENSITIZING AGENT; THIOPYRYLIUM; UNCLASSIFIED DRUG;

ARTICLE; BLOOD; CELL SUSPENSION; CONTROLLED STUDY; DRUG SENSITIVITY; ERYTHROCYTE; HUMAN; HUMAN CELL; LEISHMANIA DONOVANI; LEISHMANIASIS; NONHUMAN; PARASITE TRANSMISSION; PHOTOSENSITIZATION; PRIORITY JOURNAL; SCREENING TEST;

ANIMALS; BLOOD PRESERVATION; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; HEMOLYSIS; HUMANS; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; PHOTOSENSITIZING AGENTS; STERILIZATION;

EID: 33746441033     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2006.00810.x     Document Type: Article

References (12)

1. Myles O, Wortmann G, Barthel R, Ockenhouse C, Gasser R, Weina P, Patel S, Crum N, Groff H, Gerwaldt L: Two cases of visceral Leishmaniasis in U.S. Military Personnel - Afghanistan, 2002-04. MMWR Morb Mortal Wkly Rep 2004; 53:265-268
2. Aronson N, Ananthakrishnam M, Bernstein W, Hochberg L, Marovich M, Ockenhouse C, Yoon I, Weina P, Benson P, Fischer J, Hack D, Hawkes C, Polhemus M, Wortmann G, McEvoy P, Neafie RMA, Defraites R, Herwaldt BL: Update: Cutaneous Leishmaniasis in U.S. Military Personnel - Southwest/Central Asia, 2002-04. MMWR Morb Mortal Wkly Rep 2004; 53:264-265
3. Anonymous: Viscerotropic Leishmaniasis in persons returning from operation Desert Storm - 1990-91. MMWR Morb Mortal Wkly Rep 1992; 41:131-134
4. le Fichoux Y, Quaranta JF, Aufeuvre JP, Lelievre A, Marty P, Suffia I, Rousseau D, Kubar J: Occurrence of Leishmania infantum parasitemia in asymptomatic blood donors living in an area of endemicity in southern France. J Clin Microbiol 1999; 37:1953-1957
5. Badaro RT, Jones TC, Carvalho JM, Sampaio D, Reed SG, Barral A, Teixeira R, Johnson WD: New perspectives on a subclinical form of visceral leishmaniasis. J Infect Dis 1986; 154:1003-1011
6. Pearson RD, de Queiroz Sousa A: Clinical spectrum of leishmaniasis. Clin Infect Dis 1995; 22:1-13
7. Choi CM, Lerner EA: Leishmaniasis: recognition and management with a focus on the immunocompromised patient. Am J Clin Dermatol 2002; 3:91-105
8. Cardo LJ, Rentas FJ, Ketchum L, Salata J, Harman R, Melvin W, Weina PJ, Mendez J, Reddy H, Goodrich R: Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light. Vox Sang 2006; 90:85-91
9. Wagner SJ, Skripchenko A, Cincotta L, Thompson-Montgomery D, Awatefe H: Use of a flexible thiopyrylium photosensitizer and competitive inhibitor for pathogen reduction of viruses and bacteria with retention of red cell storage properties. Transfusion 2005; 45:752-760
10. Hogman CF, Eriksson L, Gong J, Hogman AB, Vikholm K, Debrauwere J, Payrat JM, Stewart M: Half-strength citrate CPD combined with a new additive solution for improved storage of red blood cells suitable for clinical use. Vox Sang 1993; 65:271-278
11. Finney DJ: Statistical Methods in Biological Assay, 3rd edn. New York, Macmillan Publishing Co., Inc., 1978
12. Cardo LJ, Salata JM, Harman RW, Mendez J, Weina PJ: Leukodepletion filters reduce Leishmania in blood products when used at collection or at the bedside. Transfusion 2006; 46:896-902